CVE-2023-50346: Hcltech Dryice Myxalytics

Medium severity, CVSS 4.3. EPSS: 0.3% chance of exploitation in the next 30 days.

HCL DRYiCE MyXalytics is impacted by an information disclosure vulnerability. Certain endpoints within the application disclose detailed file information.

Affected products

• Hcltech Dryice Myxalytics: version 5.9 only; version 6.0 only; version 6.1 only

Published 2024-01-03. Last modified 2026-06-17.